P640 Fatal viral opportunistic infections and Epstein-Barr virus positive large B-cell lymphoma after alemtuzumab treatment for a refractory Sezary syndrome

Autor:	O. Epaulard, N. Roch, P. Pavese, N. Sturm, G. Gereige, S. Larrat, B. Pegourie-Bandelier, J.P. Brion, A. Toffart, F. Berger, Jean-Paul Stahl, J. Guellerin, C. Dumontet, V. Hincky, F. Orsini-Piocelle, P. Morand, D. Salameire, R. Gressin, Stéphane Courby
Rok vydání:	2007
Předmět:	Microbiology (medical) business.industry Epstein-Barr Virus Positive General Medicine medicine.disease Virology Infectious Diseases Refractory Immunology Medicine Alemtuzumab Pharmacology (medical) business B-cell lymphoma medicine.drug
Zdroj:	International Journal of Antimicrobial Agents. 29:S150-S151
ISSN:	0924-8579
DOI:	10.1016/s0924-8579(07)70482-x
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3b017903dc488ee8ca4fea3f13af6511 https://doi.org/10.1016/s0924-8579(07)70482-x Zobrazit plný text záznamu Full Text from ScienceDirect